Mi Yeon Cho

Mi Yeon Cho

Auto-generated profile, based on publicly available information

Mi Yeon Cho

Department of Dermatology, Gangnam Severance Hospital, Cutaneous Biology Research Institute, Yonsei University College of Medicine, Seoul, Korea

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2023 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
DHDawoon Han
Dawoon Han
ALA Yeong Lee
A Yeong Lee
TKTaehee Kim
Taehee Kim
JCJi Young Choi
Ji Young Choi
MCMi Yeon Cho
Mi Yeon Cho
JKJong Hoon Kim
Jong Hoon Kim
BACKGROUND. Pemphigus, a rare autoimmune bullous disease mediated by antidesmoglein autoantibodies, can be controlled with systemic medication like rituximab and high-dose systemic corticosteroids combined with immunosuppressants. However, some patients continue to experience chronically recurrent blisters in a specific area and require long-term maintenance systemic therapy. METHODS. Skin with chronic blisters was obtained from patients with pemphigus. Immunologic properties of the skin were analyzed by immunofluorescence staining, bulk and single-cell RNA and TCR sequencing, and a highly multiplex imaging technique known as CO-Detection by indEXing (CODEX). Functional analyses were performed by flow cytometry and bulk RNA-Seq using peripheral blood from healthy donors. Intralesional corticosteroid was injected into patient skin, and changes in chronically recurrent blisters were observed. RESULTS. We demonstrated the presence of skin tertiary lymphoid structures (TLSs) with desmoglein-specific B cells in chronic blisters from patients with pemphigus. In the skin TLSs, CD4+ T cells predominantly produced CXCL13. These clonally expanded CXCL13+CD4+ T cells exhibited features of activated Th1-like cells and downregulated genes associated with T cell receptor–mediated signaling. Tregs are in direct contact with CXCL13+CD4+ memory T cells and increased CXCL13 production of CD4+ T cells through IL-2 consumption and TGF-β stimulation. Finally, intralesional corticosteroid injection improved chronic blisters and reduced skin TLSs in patients with pemphigus. CONCLUSION. Through this study we conclude that skin TLSs are associated with the persistence of chronically recurrent blisters in patients with pemphigus, and the microenvironmental network involving CXCL13+CD4+ T cells and Tregs within these structures plays an important role in CXCL13 production. TRIAL REGISTRATION. ClinicalTrials.gov NCT04509570. FUNDING. This work was supported by National Research Foundation of South Korea (NRF-2021R1C1C1007179) and Korea Drug Development Fund, which is funded by Ministry of Science and ICT; Ministry of Trade, Industry, and Energy; and Ministry of Health and Welfare (grant RS-2022-00165917).

1 January 2023 in Yonsei Medical Journal
Verified
Journal Article
Open access
PDF file
MCMi Yeon Cho
Mi Yeon Cho
SLSang Gyun Lee
Sang Gyun Lee
JKJee Eun Kim
Jee Eun Kim
YLYong Sang Lee
Yong Sang Lee
HCHang-Seok Chang
Hang-Seok Chang
MRMi Ryung Roh
Mi Ryung Roh
Cho MY, et al. Yonsei Med J. 2023 Nov;64(11):687-691. https://doi.org/10.3349/ymj.2023.0003

17 January 2020 in Lasers in Surgery and Medicine
Verified
Journal Article
Closed access
PDF file
MCMi Yeon Cho
Mi Yeon Cho
MRMi Ryung Roh
Mi Ryung Roh

1 January 2021 in Annals of Dermatology
Verified
Journal Article
Open access
PDF file
HPHae Seok Park
Hae Seok Park
JKJong Hoon Kim
Jong Hoon Kim
MCMi Yeon Cho
Mi Yeon Cho
KCKee Yang Chung
Kee Yang Chung
MRMi Ryung Roh
Mi Ryung Roh
Park HS, et al. Ann Dermatol. 2021 Feb;33(1):18-25. https://doi.org/10.5021/ad.2021.33.1.18

30 October 2018 in Lasers in Surgery and Medicine
Verified
Journal Article
Closed access
PDF file
JLJung Min Lim
Jung Min Lim
YOYeongjoo Oh
Yeongjoo Oh
SLSi‐Hyung Lee
Si‐Hyung Lee
MCMi Yeon Cho
Mi Yeon Cho
KCKee Yang Chung
Kee Yang Chung
MRMi Ryung Roh
Mi Ryung Roh